A pilot randomised clinical trial demonstrates that acceptance and commitment therapy (ACT) is a feasible and promising treatment for fear of cancer recurrence (FCR), a very disruptive condition affecting cancer survivors. Since the number of cancer survivors is expected to increase in the coming years, this treatment may be beneficial to a large number of people. [more]
Mammograms are unlikely to benefit older women with increased comorbidity, as they would probably die from something else before they could develop breast cancer. That is what results from a new study on more than [more]
Many cancer drugs undergoing clinical trials kill malignant cells by acting on targets different from the one they were intended to hit. This surprising finding warns against poor preclinical characterization of targets and potential drugs [more]
As a medical oncologist, I feel it as a mission to try to improve patients’ outcomes by providing the best cancer patient care. One of ECCO’s missions is coherent with this, and their aim to [more]
More than 28,500 participants from 138 countries worldwide pacifically invaded Barcelona, Spain, from September 27 to October 1, attending 299 sessions with 2,218 accepted abstracts and 93 late-breaking abstracts, during the event organized by ESMO [more]